Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1065998 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL1064301 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL1064173 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL3309655 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL3309565 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL3302601 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL4954370 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL3303123 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL1057338 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL1062564 | 0.97 | TSHR (0.47) | TSHRTHRBLMNADNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8956445-B2 | High stability diionic liquid salts | SIGMA-ALDRICH CO. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8956445-B2 | High stability diionic liquid salts | SIGMA-ALDRICH CO. (US) | 2015-02-17 | — | — | US | disclosed |
| EP-2682396-A1 | High stability diionic liquid salts | Sigma-Aldrich Co. (US) | 2014-01-08 | — | — | EP | disclosed |
| US-20120211696-A1 | HIGH STABILITY DIIONIC LIQUID SALTS | SIGMA-ALDRICH CO. LLC (US) | 2012-08-23 | — | — | US | disclosed |
| US-8168830-B2 | use of these novel ionic liquids having bis-cation or bis-anion separated by bridging group as the stationary phase in a gas chromatographic column | SIGMA-ALDRICH CO. LLC (US) | 2012-05-01 | — | — | US | disclosed |
| US-20080027231-A1 | High stability diionic liquid salts | SIGMA-ALDRICH CO. (US) | 2008-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027231-A1 | High stability diionic liquid salts | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDHD5, DAD1 | TSHR 4801/4885THRB 4836/4885LMNA 739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.